Saturday, 18 July 2026Live global desk
GlobalPulse
The world, tracked in motion
Health

DR Congo battles rare Bundibugyo Ebola outbreak amid conflict

A rare species of the Ebola virus is spreading through the Democratic Republic of Congo, compounded by violent conflict and deep community distrust.

DR Congo battles rare Bundibugyo Ebola outbreak amid conflict
DR Congo battles rare Bundibugyo Ebola outbreak amid conflict

DR Congo battles rare Bundibugyo Ebola outbreak amid conflict

A rare species of the Ebola virus is spreading rapidly through the Democratic Republic of Congo (DRC), creating what World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus described as a catastrophic collision of disease and conflict. The outbreak, caused by the Bundibugyo strain, is currently the third-worst on record.

As of 16 July, officials reported 2,073 confirmed cases and 796 confirmed deaths in the DRC. There have been 377 recoveries. The epicenter is in Ituri province, though cases have also been confirmed in South Kivu (3) and North Kivu (189). The latter two provinces are partly controlled by the rebel AFC-M23 alliance.

A Rare and Untreated Strain

The Bundibugyo species was first detected in Uganda in 2007 and has only caused two previous outbreaks, in 2007 and 2012. Unlike the more common Zaire and Sudan species, there are currently no approved vaccines or drugs specifically for the Bundibugyo strain. This is due to a 35 percent genetic difference in the outer glycoprotein coat of the virus, meaning antibodies produced by Zaire-strain vaccines cannot bind to the Bundibugyo strain.

Historically, the Bundibugyo strain has shown Case Fatality Rates between 30 percent and 50 percent. In the current outbreak, approximately 38 percent of those known to be infected have died.

Medical responses are currently fragmented. The WHO is sponsoring clinical trials in the DRC to test whether remdesivir and an experimental monoclonal antibody called MBP134 can improve survival. Meanwhile, the UK's MHRA permitted the first human trials of a University of Oxford vaccine in July. Developed in eight weeks using technology from the Oxford-AstraZeneca Covid vaccine, the jab will be tested on 50 volunteers aged 18 to 55.

Conflict and Community Resistance

The health crisis is unfolding in a region plagued by decades of violence. Militias backing the Hema and Lendu ethnic groups have killed more than 50,000 people and displaced millions.

Violence has directly hindered medical efforts. In the mining zone of Rwampara, locals burned an Ebola treatment center after being denied the body of a deceased friend. Similarly, a treatment tent in Mongbwalu was burned, causing at least 18 suspected patients to flee.

Public distrust is deep-seated. Congolese Health Minister Samuel Roger Kamba stated that some communities believe the disease is witchcraft or a mystical illness, leading them to seek help from witchdoctors or prayer centers. This suspicion is fueled by a history of foreign intervention and a 2018 to 2020 response where WHO personnel were documented committing widespread sexual exploitation and abuse.

Environmental and Logistical Barriers

The outbreak is linked to environmental destruction in the Congo Basin. In 2024, mining and logging destroyed 1.5 million acres of rainforest, pushing fruit bats—the natural reservoirs of Ebola—into closer contact with human mining communities in towns like Mongbwalu.

Logistics further complicate the response. A 90km journey from Bunia to Mongbwalu can take more than three hours due to poor roads. Initial diagnostic delays occurred because local clinics lacked Polymerase Chain Reaction (PCR) testing, which requires stable electricity and a cold-chain for reagents. The virus likely circulated undetected in Mongbwalu as early as February 2026, but confirmation of the Bundibugyo strain did not arrive until 15 May 2026.

International Impact and Containment

The virus has crossed borders. Uganda recorded 20 confirmed cases and two deaths before discharging its last patient on 16 July. Uganda must now go 42 days without a new case to be declared Ebola-free. A French doctor working with ALIMA also fell ill mid-flight from Kinshasa to Paris in late June.

Containment measures include:

  • Banning mass gatherings in Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele provinces, as well as in the capital, Kinshasa.
  • Establishing four laboratories in Bunia, Mongbwalu, Beni, and Aru to deliver blood test results within 24 hours.
  • U.S. Travel restrictions requiring citizens returning from the DRC to spend 21 days in a third country.
  • Suspension of public transport and flights crossing the Uganda-DRC border.

Financial support includes $3.9 million from the WHO and a $319 million budget from the Africa CDC. Total international pledges are roughly $500 million, including $23 million from the U.S. Government and $15 million from the Bill & Melinda Gates Foundation.

Reporting based on coverage by apnews.com.

Related stories